GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (FRA:RER1) » Definitions » Cyclically Adjusted PB Ratio

Recordati SpA (FRA:RER1) Cyclically Adjusted PB Ratio : 7.53 (As of Jun. 06, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Recordati SpA Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Recordati SpA's current share price is €47.84. Recordati SpA's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €6.35. Recordati SpA's Cyclically Adjusted PB Ratio for today is 7.53.

The historical rank and industry rank for Recordati SpA's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:RER1' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.31   Med: 9.05   Max: 12.3
Current: 7.44

During the past years, Recordati SpA's highest Cyclically Adjusted PB Ratio was 12.30. The lowest was 6.31. And the median was 9.05.

FRA:RER1's Cyclically Adjusted PB Ratio is ranked worse than
89.89% of 732 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs FRA:RER1: 7.44

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Recordati SpA's adjusted book value per share data for the three months ended in Mar. 2024 was €8.808. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6.35 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Recordati SpA Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Recordati SpA's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Cyclically Adjusted PB Ratio Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.06 10.20 11.39 6.55 7.70

Recordati SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.49 7.12 7.12 7.70 7.91

Competitive Comparison of Recordati SpA's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Recordati SpA's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Cyclically Adjusted PB Ratio falls into.



Recordati SpA Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Recordati SpA's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=47.84/6.35
=7.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Recordati SpA's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=8.808/120.2000*120.2000
=8.808

Current CPI (Mar. 2024) = 120.2000.

Recordati SpA Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.811 100.093 4.577
201409 4.008 99.814 4.827
201412 3.852 99.721 4.643
201503 4.231 99.814 5.095
201506 4.279 100.279 5.129
201509 4.377 100.000 5.261
201512 4.234 99.814 5.099
201603 4.461 99.600 5.384
201606 4.522 99.900 5.441
201609 4.815 100.100 5.782
201612 4.404 100.300 5.278
201703 4.856 101.000 5.779
201706 4.829 101.100 5.741
201709 5.065 101.200 6.016
201712 4.932 101.200 5.858
201803 4.480 101.800 5.290
201806 4.451 102.400 5.225
201809 4.843 102.600 5.674
201812 4.723 102.300 5.549
201903 5.232 102.800 6.118
201906 5.252 103.100 6.123
201909 5.730 102.900 6.693
201912 5.824 102.800 6.810
202003 6.038 102.900 7.053
202006 6.033 102.900 7.047
202009 6.240 102.300 7.332
202012 6.185 102.600 7.246
202103 6.441 103.700 7.466
202106 6.435 104.200 7.423
202109 7.002 104.900 8.023
202112 6.710 106.600 7.566
202203 7.051 110.400 7.677
202206 7.267 112.500 7.764
202209 7.838 114.200 8.250
202212 7.526 119.000 7.602
202303 8.057 118.800 8.152
202306 7.836 119.700 7.869
202309 8.374 120.300 8.367
202312 8.186 119.700 8.220
202403 8.808 120.200 8.808

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Recordati SpA  (FRA:RER1) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Recordati SpA Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA (FRA:RER1) Business Description

Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (FRA:RER1) Headlines

No Headlines